Axon Enterprise, Inc. (NASDAQ:AXON – Get Free Report) Director Caitlin Elizabeth Kalinowski sold 450 shares of the stock in a transaction dated Thursday, January 2nd. The shares were sold at an average price of $604.07, for a total value of $271,831.50. Following the completion of the transaction, the director now directly owns 6,929 shares in the company, valued at $4,185,601.03. This represents a 6.10 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink.
Axon Enterprise Stock Up 0.8 %
NASDAQ AXON opened at $601.06 on Friday. Axon Enterprise, Inc. has a one year low of $241.72 and a one year high of $698.67. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96. The business has a fifty day moving average price of $593.68 and a 200 day moving average price of $440.17. The company has a market cap of $45.83 billion, a P/E ratio of 155.31, a P/E/G ratio of 14.19 and a beta of 1.04.
Wall Street Analysts Forecast Growth
AXON has been the subject of a number of recent research reports. Morgan Stanley raised shares of Axon Enterprise from an “equal weight” rating to an “overweight” rating and raised their price target for the stock from $500.00 to $700.00 in a research report on Tuesday, December 3rd. Needham & Company LLC raised their target price on shares of Axon Enterprise from $525.00 to $600.00 and gave the stock a “buy” rating in a report on Friday, November 8th. JMP Securities upped their price target on shares of Axon Enterprise from $430.00 to $500.00 and gave the company a “market outperform” rating in a report on Thursday, October 31st. The Goldman Sachs Group lifted their price objective on Axon Enterprise from $385.00 to $441.00 and gave the company a “buy” rating in a research note on Wednesday, October 23rd. Finally, Northland Securities raised their target price on Axon Enterprise from $365.00 to $550.00 and gave the stock an “outperform” rating in a report on Monday, November 11th. One analyst has rated the stock with a hold rating and thirteen have given a buy rating to the stock. According to MarketBeat, Axon Enterprise presently has an average rating of “Moderate Buy” and an average target price of $488.67.
Institutional Investors Weigh In On Axon Enterprise
A number of hedge funds have recently modified their holdings of AXON. Everence Capital Management Inc. grew its stake in Axon Enterprise by 14.0% during the 4th quarter. Everence Capital Management Inc. now owns 1,550 shares of the biotechnology company’s stock valued at $921,000 after acquiring an additional 190 shares in the last quarter. GAMMA Investing LLC grew its position in shares of Axon Enterprise by 32.0% in the fourth quarter. GAMMA Investing LLC now owns 1,300 shares of the biotechnology company’s stock valued at $773,000 after purchasing an additional 315 shares in the last quarter. Versant Capital Management Inc increased its holdings in shares of Axon Enterprise by 4,750.0% in the fourth quarter. Versant Capital Management Inc now owns 97 shares of the biotechnology company’s stock valued at $58,000 after purchasing an additional 95 shares during the last quarter. Principal Financial Group Inc. lifted its position in Axon Enterprise by 33.1% during the third quarter. Principal Financial Group Inc. now owns 136,302 shares of the biotechnology company’s stock worth $54,466,000 after buying an additional 33,869 shares in the last quarter. Finally, Brass Tax Wealth Management Inc. acquired a new position in Axon Enterprise during the third quarter worth $240,000. 79.08% of the stock is currently owned by institutional investors and hedge funds.
About Axon Enterprise
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
Featured Stories
- Five stocks we like better than Axon Enterprise
- 5 discounted opportunities for dividend growth investors
- Quantum Opportunity: Skywater Technology’s Long-Term Potential
- What is the Nasdaq? Complete Overview with History
- Nebius Group: The Rising Star in AI Infrastructure
- What is the S&P/TSX Index?
- MarketBeat Week in Review – 12/30 – 1/03
Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.